COVID testing-related sales for Abbott totaled $69 million in the most recent quarter, down significantly from $265 million in the same period last year. (Abbott) Medical devices continue to be a ...
Abbott Laboratories said Wednesday it received federal emergency use authorization for its rapid COVID-19 test to be used at peoples' homes, with results available in 15 minutes. The medical device ...
Abbott stock jumped Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests. Sales at Abbott Laboratories' (ABT) other segments, though, "were modestly better than the ...
Abbott's diabetes segment fared particularly well: CEO Robert Ford touted the FreeStyle Libre continuous glucose monitor’s $5.3 billion in 2023 sales and 24% growth in the fourth quarter alone, adding ...
Abbott Laboratories (Abbott), a world-leading medical devices and healthcare company, is one of the leaders in Covid-19 testing with its three diagnostic PCR tests: the ID NOW, m2000, and Alinity m.
Abbott has scored yet another Emergency Use Authorization for rapid coronavirus testing – this one, named BinaxNOW COVID-19 Ag Card, come in the form of a card and can provide results in 15 minutes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results